NEW YORK (GenomeWeb News) - DeltaDot and Integrated Technologies said today they have received a £465,000 ($900,000) grant from the South East England Development Agency to develop a new tool that will use protein folding structures to help speed drug development.
The system, called the Osprey Biomolecule Stability Analyzer, is a microfluidic instrument that uses DeltaDot's Label Free Intrinsic Imaging to characterize protein properties. The system is being developed to test drug candidates against protein structures and dynamics, the company said.
The company is targeting the market for biopharmaceutical quality assurance as the first application for Osprey.
ITL director Greg Smith said that the technology is expected to “reduce drug selection times dramatically.”